Article Details
Retrieved on: 2021-08-17 06:33:45
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
About Tafasitamab Tafasitamab is a humanized Fc-modified cytolytic CD19 targeting monoclonal antibody. In 2010, MorphoSys licensed exclusive ...
Article found on: www.marketwatch.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here